 |
 |
|
|
|
 |
||||
 |
||||
 |
||||
 |
||||
 |
||||
 |
||||
 |
||||
 |
||||
 |
||||
 |
||||
 |
||||
 |
||||
 |
||||
 |
||||
 |
||||
 |
 |
 |
 |
 |
 |
||||
 | |||||
|
Paris - Avril 2010 - Ministère de la Santé |
 |
Centre d’Analyse Stratégique - Mars 2010 - Sara-Lou Gerber |
|
CDRH - Center for Devices and Radiological Health - 5 Février 2010 - Dr. Greg Campbell |
|
Version 1.0 - 19/11/2009 - IQWIG |
|
Décembre 2009 - Haute Autorité de Santé |
|
Décembre 2009. - Centre for Review and Dissemination - NHS Economic Evaluation Database (NHS EED) |
|
Haute autorité de Santé- 9 septembre 2009 - Voir page 12 - position de la CT sur les méta-analyses multitraitement |
|
- US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), Center for Devices and Radiological Health (CDRH) |
|
ISPOR 12th Annual European Congress, October 2009, Paris - Evelina Zimovetz, Sorrel Wolowacz - RTI Health Solutions, Manchester, United Kingdom |
|
REPORT BRIEF • JUNE 2009 - Institute of Medicine |
|
- June 30, 2009 |
|
CRD, University of York - Janvier 2009 - Center for Reviews and Dissemination |
|
Lettre de l’OFCE - n°301 - 15 Septembre 2008 - Mireille ELBAUM |
|
Juin 2008 - NHS - National Institute for Health and Clinical Excellence |
|
Numéro 1 - Septembre 2008 - Cahiers de l’Evaluation - Centre d’Analyse Stratégique |
|
- EFPIA - European Federation of Phramaceutical Industries and Associations. |
|
11 juillet 2007 - First Public Draft |
|
2001 - Rapport Marcel Boiteux. Commissariat Général du plan. |
|
2005 - Ministère de l’équipement. |
|
- KCE Reports 78B : 2008. |
|
- Secrétariat du Conseil du Trésor du Canada |
|
Institue for Quality and Efficiency in Health Care - 10th October, 2008 |
|
First Report of Session 2007-08 - House of Commons Health Committee |
|
Written Evidence - House of Commons Health Committee. |
|
Draft for consultation, January 2008 - Nice Guideline |
|
Annual report - 2008 - Institute of Medicine USA - Roundtable on evidence-based medicine |
|
Review of the ’Guide to Methods of Technology Appraisal’ - National Institute for Health and Clinical Excellence. |
|
Review of the ’Guide to Methods of Technology Appraisal’ - National institute for Health and Clinical Excellence |
|
Draft for consultation. November 2007. - National Institute for Health and Clinical Excellence. |
|
Office of Fair Trading - An OFT market study. November 2007. |
|
Septembre 2007. |
|
Canada, Mai 2007. - Conseil d’examen du prix des médicaments brevetés. |
|
2005 - The Cochrane Collaboration 2005. |
|
ENCC MCO Mai 2007. - Publication ATIH |
|
Septembre 2007. |
|
Centre for Health Economics, University of York. - Mark Sculpher, Karl Claxton, Mike Drummond |
|
eunethta - 2007 - First Public Draft (revised) |
|
NICE - 2006 - Specification for Manufacturer / Sponsor submission of evidence |
|
Ph. Ravaud, P. Durieux - Haute Autorité de Santé - Guide Méthodologique |
|
- CCOHTA, 3rd Edition, 2006. |
|
|
Ministère de la santé - Ministère de la Santé, de la famille et des personnes handicapées. Août 2003. |
|
Com Ruelle L, Dourgnon P., Perronin M., Thomas R. - IRDES, Juillet 2003. |
|
|
- ADELF, ADEREST, AEEMA, EPITER. |
|
- Document interne, Direction Générale de la Santé, Janvier 2002. |
|
|
- Franco Sassi, LSE. |
|
- Mark V. Pauly, Henry Glick, Wharton. |
|
- John A. Nyman, Ph.D |
|
- Mark Roberts, MD MPP |
|
Commissariat Général du Plan - 2005 - Daniel Lebègue |
|
Fourth Report of Session 2004-05 - House of Commons Health Committee |
|
- NICE, Chairman : Professor Sir Mickael Rawlins, May 2004. |
|
- Parkin D., Devlin N. City Health Economics Centre, City University, London, 2003. |
|
 |
INCA Journée Scientifique : Evaluation de la Qualité de vie des Personnes Atteintes de Cancer.
